GranaProstan by Dr. Jacob's 500 ml

The GranaProstan ferment 500ml dietary supplement from Dr. Jacob's is a product containing juice and pulp from pomegranate fruits and elderberry polyphenols.

The supplement is obtained by fermentation with probiotic bacteria. This treatment makes the ingredients more accessible to the body. Jacob's GranaProstan also contains less sugar than fresh juice from the Punica granatum fruit. This means it can be consumed by people suffering from hyperglycemia.

The product is made without zoonotic additives, so this supplement can also be used by vegans.

According to research, pomegranate juice may have properties that reduce lipid peroxidation and act as an antioxidant. Interestingly, it also increases the production of nitric oxide, which naturally dilates blood vessels [1].

Polyphenols are organic compounds of plant origin, belonging to the phenolic group, which have at least two hydroxyl groups attached to the aromatic ring. Many of them exhibit strong antioxidant properties.

Black elderberry is also an antioxidant, but it also helps maintain normal blood sugar levels. Additionally, it strengthens immunity and has a beneficial effect on the upper respiratory tract after irritation. Furthermore, it promotes blood circulation and cares for the condition of blood vessels.

It is interesting to note that Sambucus nigra L. also plays a role in less obvious processes. When used as part of a diet, it facilitates weight loss, helping to maintain it at a healthy level. Moreover, it contributes to increasing the release of water from the body.

In conclusion, the dietary supplement Dr. Jacob's GranaProstan ferment 500ml is a natural plant-based product that has antioxidant and immune-supporting properties.

1 Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 1;12(13):4018-26. doi: 10.1158/1078-0432.CCR-05-2290. PMID: 16818701.